| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |